bf/NASDAQ:ANTX_icon.jpeg

COM:AN2THERAPEUTICS

AN2 Therapeutics

  • Stock

USD

Last Close

1.23

22/11 21:00

Market Cap

77.56M

Beta: -

Volume Today

1.25M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
Sep '24
net income
-2.05M
-
-5.01M
144.48%
-6.94M
38.67%
-7.54M
8.67%
-7.66M
1.46%
-10.12M
32.20%
-11.34M
12.05%
-11.84M
4.44%
-15.32M
29.40%
-15.80M
3.14%
-16.71M
5.71%
-16.90M
1.14%
-16.62M
1.66%
-12.75M
-
depreciation and amortization
1K
-
20K
-
-692K
3,560%
-435K
37.14%
21K
104.83%
deferred income tax
-1K
-
-20K
-
-21K
-
stock based compensation
8K
-
179K
2,137.50%
354K
97.77%
433K
22.32%
449K
3.70%
1.24M
176.61%
1.23M
1.13%
1.47M
19.87%
2.07M
40.49%
1.94M
6.04%
2.17M
11.63%
2.38M
-
1.90M
-
change in working capital
497K
-
-440K
188.53%
1.88M
527.05%
-1.90M
201.33%
445K
123.37%
-663K
248.99%
849K
228.05%
3.09M
263.60%
2.08M
32.78%
1.48M
28.82%
3.38M
128.71%
-1.10M
132.45%
-2.27M
107.12%
3.60M
-
accounts receivables
inventory
accounts payables
379K
-
273K
27.97%
711K
160.44%
-946K
233.05%
1.55M
263.42%
441K
71.47%
-171K
138.78%
681K
498.25%
1.42M
108.96%
-414K
129.09%
1.65M
498.79%
-2.11M
227.62%
-243K
88.47%
-174K
-
other working capital
118K
-
-713K
704.24%
1.17M
263.81%
-958K
182.02%
-1.10M
14.93%
-1.10M
0.27%
1.02M
192.39%
2.41M
135.88%
652K
72.90%
1.89M
190.03%
1.73M
8.67%
1.01M
41.46%
-2.03M
300.49%
3.77M
-
other non cash items
11K
-
19K
72.73%
23K
21.05%
19K
17.39%
-54K
384.21%
-225K
316.67%
337K
249.78%
19K
94.36%
-440K
2,415.79%
-640K
45.45%
926K
244.69%
1.54M
65.98%
-4.76M
-
net cash provided by operating activities
-1.54M
-
-5.26M
240.70%
-4.69M
10.77%
-8.99M
91.71%
-6.74M
25.03%
-9.60M
42.32%
-9.49M
1.13%
-7.64M
19.49%
-11.60M
51.82%
-12.82M
10.59%
-11.80M
7.99%
-17.07M
44.64%
-17.59M
3.08%
-12.01M
-
investments in property plant and equipment
acquisitions net
purchases of investments
-49.28M
-
-11.99M
75.68%
-16.00M
33.52%
-998K
93.76%
-52.99M
5,209.22%
-22.41M
57.71%
-17.45M
22.14%
-14.01M
19.67%
-13.12M
6.35%
-85.21M
549.33%
-19.83M
76.73%
-9.78M
-
sales maturities of investments
5M
-
22.25M
345%
14.97M
32.70%
13.50M
9.85%
20.09M
48.81%
23.50M
16.97%
24.90M
5.96%
21M
15.66%
22.75M
8.33%
20.25M
10.99%
26.29M
29.83%
28.50M
-
other investing activites
net cash used for investing activites
-49.28M
-
-6.99M
85.83%
6.25M
189.41%
13.98M
123.78%
-39.49M
382.51%
-2.32M
94.13%
6.05M
361.33%
10.89M
79.80%
7.88M
27.65%
-62.46M
892.97%
420K
100.67%
26.29M
6,159.52%
18.72M
-
debt repayment
common stock issued
63.20M
-
7.18M
88.64%
-10K
100.14%
70.38M
703,860%
199K
99.72%
19.05M
9,472.86%
65.80M
245.41%
-321K
100.49%
349K
208.72%
-202K
-
common stock repurchased
-10
-
dividends paid
-1.82M
-
-1.82M
0%
-1.82M
-
other financing activites
79.74M
-
-240K
-
-969K
303.75%
1.81M
286.69%
1.82M
0.61%
10
100.00%
1.81M
18,089,900%
266K
-
225K
-
23K
-
net cash used provided by financing activities
79.74M
-
-240K
-
-969K
303.75%
63.19M
6,620.85%
7.18M
88.64%
-10K
100.14%
70.36M
703,750%
199K
99.72%
19.05M
9,472.86%
66.07M
246.80%
-321K
100.49%
349K
208.72%
23K
-
effect of forex changes on cash
-70.36M
-
net change in cash
78.20M
-
-54.54M
169.74%
-11.92M
78.15%
-3.72M
68.82%
70.42M
1,995.10%
-41.90M
159.50%
-11.81M
71.81%
-1.58M
86.60%
-510K
67.78%
14.10M
2,865.29%
-8.20M
158.12%
-16.97M
107.04%
9.05M
153.31%
6.74M
-
cash at beginning of period
4.07M
-
82.27M
1,921.40%
27.73M
66.29%
15.81M
42.98%
12.10M
23.50%
82.52M
582.14%
40.62M
50.78%
28.80M
29.09%
27.22M
5.50%
26.71M
1.87%
40.81M
52.80%
32.62M
20.08%
15.65M
52.03%
26.77M
-
cash at end of period
82.27M
-
27.73M
66.29%
15.81M
42.98%
12.10M
23.50%
82.52M
582.14%
40.62M
50.78%
28.80M
29.09%
27.22M
5.50%
26.71M
1.87%
40.81M
52.80%
32.62M
20.08%
15.65M
52.03%
24.69M
57.81%
33.50M
-
operating cash flow
-1.54M
-
-5.26M
240.70%
-4.69M
10.77%
-8.99M
91.71%
-6.74M
25.03%
-9.60M
42.32%
-9.49M
1.13%
-7.64M
19.49%
-11.60M
51.82%
-12.82M
10.59%
-11.80M
7.99%
-17.07M
44.64%
-17.59M
3.08%
-12.01M
-
capital expenditure
free cash flow
-1.54M
-
-5.26M
240.70%
-4.69M
10.77%
-8.99M
91.71%
-6.74M
25.03%
-9.60M
42.32%
-9.49M
1.13%
-7.64M
19.49%
-11.60M
51.82%
-12.82M
10.59%
-11.80M
7.99%
-17.07M
44.64%
-17.59M
3.08%
-12.01M
-

All numbers in USD (except ratios and percentages)